Follow The Filings

Telix Pharmaceutical position history

The shares of Telix Pharmaceutical that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, SPONSORED ADS

Shares held by quarter

New Add Reduce Exit

  1. 2026 Q3: 419,000 shares, $4.6M, 0.02% of portfolio, New
Holdings date Value % of holdings Shares Filing date All 13F holders